430 related articles for article (PubMed ID: 32740213)
1. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH
Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213
[TBL] [Abstract][Full Text] [Related]
2. Practice habits of Mohs surgeons treating melanoma with Mohs surgery: A cross-sectional survey.
Siscos SM; Neill BC; Seger EW; Rajpara A; Hocker TLH
J Am Acad Dermatol; 2021 Mar; 84(3):833-835. PubMed ID: 33022309
[No Abstract] [Full Text] [Related]
3. Mohs Micrographic Surgery for the Treatment of Melanoma: A Cross-Sectional Survey on the Barriers, Prevalence, and Practice.
Orfaly VE; Hagstrom EL; Leitenberger JJ; Latour E; Bar A
Dermatol Surg; 2021 Aug; 47(8):1114-1115. PubMed ID: 33587372
[No Abstract] [Full Text] [Related]
4. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986
[TBL] [Abstract][Full Text] [Related]
5. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
6. Mohs micrographic surgery for melanoma: A prospective multicenter study.
Ellison PM; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
[TBL] [Abstract][Full Text] [Related]
7. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
Stigall LE; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
[TBL] [Abstract][Full Text] [Related]
8. Utilization Patterns of Fellowship-Trained Mohs Surgeons in the Treatment of Melanoma in Situ and Melanoma.
Barklund JS; Cameron MC; Mirhossaini RB; Brown M
Dermatol Surg; 2021 Jun; 47(6):814-815. PubMed ID: 32932262
[No Abstract] [Full Text] [Related]
9. Factors Deterring the Utilization of Mohs Surgery for Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Siscos SM; Neill BC; Seger EW; Hocker TLH
Dermatol Surg; 2021 May; 47(5):709-710. PubMed ID: 33905398
[No Abstract] [Full Text] [Related]
10. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
[TBL] [Abstract][Full Text] [Related]
11. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.
Nosrati A; Berliner JG; Goel S; McGuire J; Morhenn V; de Souza JR; Yeniay Y; Singh R; Lee K; Nakamura M; Wu RR; Griffin A; Grimes B; Linos E; Chren MM; Grekin R; Wei ML
JAMA Dermatol; 2017 May; 153(5):436-441. PubMed ID: 28241261
[TBL] [Abstract][Full Text] [Related]
13. Factors Influencing General Dermatologists When Referring Patients With Head and Neck Melanoma for Mohs Micrographic Surgery: A Nationwide Cross-Sectional Survey.
Neill BC; Siscos SM; Bar AA; Seger EW; Latour E; Tolkachjov SN
Dermatol Surg; 2023 May; 49(5):451-455. PubMed ID: 36989088
[TBL] [Abstract][Full Text] [Related]
14. Upstaging of melanoma in situ and lentigo maligna treated with Mohs micrographic surgery rarely results in additional surgical management.
Levoska MA; Schmults CD; Waldman AH
Arch Dermatol Res; 2020 Dec; 312(10):753-756. PubMed ID: 32002653
[TBL] [Abstract][Full Text] [Related]
15. Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas.
Shin TM; Nugent S; Aizman L; Weiner DM; O'Malley V; Sobanko JF; Etzkorn JR; Chu EY; Elenitsas R; Giordano CN; Higgins Ii HW; Miller CJ
J Am Acad Dermatol; 2021 Jan; 84(1):196-198. PubMed ID: 32339704
[No Abstract] [Full Text] [Related]
16. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
17. Outlier Practice Patterns in Mohs Micrographic Surgery: Defining the Problem and a Proposed Solution.
Krishnan A; Xu T; Hutfless S; Park A; Stasko T; Vidimos AT; Leshin B; Coldiron BM; Bennett RG; Marks VJ; Brandt R; Makary MA; Albertini JG;
JAMA Dermatol; 2017 Jun; 153(6):565-570. PubMed ID: 28453605
[TBL] [Abstract][Full Text] [Related]
18. Nail Unit Melanoma In Situ Treated With Mohs Micrographic Surgery.
Matsumoto A; Strickland N; Nijhawan RI; Srivastava D
Dermatol Surg; 2021 Jan; 47(1):98-103. PubMed ID: 32796325
[TBL] [Abstract][Full Text] [Related]
19. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
20. Mohs micrographic surgery for the treatment of malignant melanoma.
Whalen J; Leone D
Clin Dermatol; 2009; 27(6):597-602. PubMed ID: 19880047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
